The Beneficial Effects of Oral Trimethoprim or Cotrimoxazole in Patients with Severe COVID-19: A Case Series
Authors:
Preprint
- 10 June 2020
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
COVID-19 may become a critical illness which is thought to be mediated by a cytokine storm syndrome. There is no effective anti-viral treatment to date and the mainstay of treatment is supportive. We treated 22 patients with severe COVID-19 with oral trimethoprim (TMP) or cotrimoxazole (CTX) in addition to standard antibiotic therapy (ST) and compared this with 22 patients with severe COVID-19 receiving standard therapy alone. We observed that the patients with severe COVID-19 receiving TMP/CTX in addition to ST had significantly better outcomes including reduced in-patient mortality (5% versus 32%), length of hospital stay (mean, 9 versus 22 days), and the need for ventilatory support (numbers, 3 versus 16) with improved clinical parameters within 48 hours of starting treatment. This may be due to the anti-cytokine effects of TMP/CTX. Urgent clinical trials are recommended.Keywords
This publication has 21 references indexed in Scilit:
- Association Between Peripheral Blood Oxygen Saturation (SpO 2 )/Fraction of Inspired Oxygen (FiO 2 ) Ratio Time at Risk and Hospital Mortality in Mechanically Ventilated PatientsThe Permanente Journal, 2020
- Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activationScience Translational Medicine, 2019
- Severe Pneumonia Caused by Coinfection With Influenza Virus Followed by Methicillin-Resistant Staphylococcus aureus Induces Higher Mortality in MiceFrontiers in Immunology, 2019
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockadeNature Medicine, 2018
- P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?2017
- New development in studies of formyl-peptide receptors: critical roles in host defenseJournal of Leukocyte Biology, 2015
- The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulationWest Indian Medical Journal, 2006
- Antibiotics as Anti-Inflammatory and Immunomodulatory Agents2005
- Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+.Proceedings of the National Academy of Sciences, 1990
- COMPARISON OF TRIMETHOPRIM ALONE WITH TRIMETHOPRIM SULPHAMETHOXAZOLE IN THE TREATMENT OF RESPIRATORY AND URINARY INFECTIONS WITH PARTICULAR REFERENCE TO SELECTION OF TRIMETHOPRIM RESISTANCEThe Lancet, 1980